TXN and glioblastoma: Glioblastoma cells adapt to the oxidative stress induced by chemotherapy by upregulating antioxidant systems such as glutathione (GSH) and thioredoxin (Trx), as well as enzymes such as superoxide dismutase (SOD) and catalase (CAT), thus promoting survival and contributing to therapy resistance [10].